Zivo Bioscience, Inc.
ZIVO
$17.90
$1.408.49%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Net Income | -2.27M | -8.24M | -1.28M | -1.91M | -1.82M |
Total Depreciation and Amortization | -- | -- | -- | -- | -- |
Total Amortization of Deferred Charges | -- | -- | -- | 4.90K | 219.80K |
Total Other Non-Cash Items | 1.09M | 7.58M | 136.70K | 103.30K | 74.20K |
Change in Net Operating Assets | 90.80K | 37.70K | -557.30K | 1.08M | -438.60K |
Cash from Operations | -1.09M | -623.70K | -1.70M | -715.70K | -1.97M |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -- | -- | -- | -- | -- |
Total Debt Issued | 0.00 | 0.00 | 517.60K | 150.00K | 0.00 |
Total Debt Repaid | -172.50K | -172.50K | -57.50K | -1.28M | -201.90K |
Issuance of Common Stock | 1.41M | 660.00K | 1.10M | 640.00K | 3.64M |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 1.24M | 487.50K | 1.56M | -494.50K | 3.43M |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 156.90K | -136.20K | -135.70K | -1.21M | 1.46M |